What Elevage Medical Technologies does

Elevage Medical Technologies is an Austin, Texas-based private investment firm formed in May 2023 by Patient Square Capital with a $300 million capital commitment. The firm provides growth-stage medical technology companies with equity capital and strategic operational support, targeting companies developing FDA-regulated medical devices, diagnostics, lab tools, and tech-enabled healthcare services. Its headquarters and secondary office are both located in Austin, and the firm operates with a lean team of 11-50 employees under CEO Dr. Evan Melrose.

Elevage's portfolio comprises ten disclosed companies spanning diverse medtech verticals: Imperative Care ($100M convertible note, stroke and thromboembolic disease), SetPoint Medical ($140M Series C/D, neuroimmune modulation for autoimmune disease), Nuclera ($87M Series C, protein engineering tools), Nervonik ($52.5M Series B, peripheral nerve stimulation for chronic pain), Biobeat ($50M Series B, cuff-less ambulatory blood pressure monitoring), and five earlier-stage or minority positions (Elucid, 4basebio, Moximed, Fire1 Foundry, Galvanize Tx). Elevage has served as lead or co-lead investor on multiple rounds and takes portfolio company board seats to provide hands-on governance and operational guidance.

The firm's revenue model is investment-driven, generating returns through equity appreciation, exit events (acquisitions, IPOs), and distributions, with underlying management fees on its $300M committed pool as the recurring base. Go-to-market relies on direct investment relationships, co-investment with institutional healthcare investors such as Perceptive Advisors, OrbiMed, and Ally Bridge Group, healthcare investment conferences, and earned media from portfolio company announcements. Operating geographies span the United States, United Kingdom, and Israel, with portfolio-driven reach into APAC and the Middle East via Nuclera.

Name

Elevage Medical Technologies

Legal name

Elevage Medical Technologies

Website

https://elevagemedicaltechnologies.com

Company type

Private

Founded year

2023

Operating status

Operating

Headcount range

11–50 employees

Short description

Elevage Medical Technologies is an Austin-based private investment firm, formed in 2023 by Patient Square Capital with $300M in committed capital, providing growth equity and strategic operational support to growth-stage medical device, diagnostics, lab tools, and health tech companies.

Ownership category

akta.pro rank

Product category

Medtech Growth Capital

NAICS

Professional, Scientific, and Technical Services (54)

SIC

Investment Advice (6282), Surgical & Medical Instruments & Apparatus (3841), Electromedical & Electrotherapeutic Apparatus (3845)

akta.pro primary industry

Health, Pharmaceuticals & Medical Devices Regulatory Cooperation (BPADANAJ)

akta.pro secondary industry

Electronic Lab Notebooks (ELN) (HLAGAJAB)

Keywords

• Medtech growth capital
• Medical device investment
• Healthcare growth equity
• Medtech strategic support
• Growth-stage venture investing

Headquarters

HQ city

Austin

HQ country

United States

HQ region

North America

Offices2 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Others

Revenue model

1. Investment Returns / Capital Gains: Elevage Medical Technologies generates returns through equity investments in growth-stage medtech companies. As a portfolio company backed by Patient Square Capital's $300 million investment, Elevage provides capital and strategic support to portfolio companies, with returns realized through equity appreciation, exit events (acquisitions, IPOs), and distributions to investors.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

Core offering

Elevage Medical Technologies is a growth-stage investment and strategic support firm that deploys equity capital and operational expertise into medical technology companies. It invests in FDA-regulated medical devices, diagnostics, lab tools, and tech-enabled healthcare services, partnering with founders and management teams to accelerate FDA approval and commercialization. Backed by a $300 million commitment from Patient Square Capital, Elevage takes equity positions and provides hands-on operational guidance, including board participation.

Product overview

Elevage Medical Technologies is a medical technology investment and strategic support company that provides capital and operational assistance to growth-stage medtech companies. Rather than offering a unified software product, Elevage serves as a collaborative partner to portfolio companies across three focus areas: Medical Devices & Diagnostics (FDA-regulated devices and diagnostics), Lab Tools (advanced life science tools and diagnostic solutions), and Healthcare IT & Tech-Enabled Services (software solutions and tech-enabled healthcare services). The portfolio includes investments in Elucida, Nuclera, 4basebio, Moximed, Fire1 Foundry, SetPoint Medical, GalvanizeTx, Biobeat, Imperative Care, and Nervonik.

Differentiator

Problem solved

Functional benefit

Products and services

• Growth-stage equity investment
• Strategic operational support

Quantifiable outcome

• Accelerated pace of innovation in medical technology for portfolio companies
• +1 more outcomes

Segments1 record

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Scale indicators6 records

Recent moves7 records

Expansion highlights4 records

Direct peers

• Ally Bridge Group: Healthcare-focused investment firm spanning venture, growth, and cross-border medtech deals. Comparable as a co-lead with Elevage in SetPoint Medical ($140M) and Biobeat ($50M), targeting similar growth-stage medtech assets globally.
• Amzak Health: Healthcare-focused growth equity firm investing in commercial-stage medical device and health tech. Comparable as the lead investor on Nervonik's Series B where Elevage participated, indicating overlapping sector focus and deal involvement.
• HealthQuest Capital: Healthcare growth equity firm focused on commercial-stage medical devices, diagnostics, and tech-enabled services. Directly comparable in target company profile (growth-stage medtech with regulatory and commercialization milestones) and operating support model.
• OrbiMed Advisors: Healthcare-dedicated investment firm across medtech, biotech, and diagnostics. Comparable as a sector-specialist investor that co-leads growth-stage medtech rounds; OrbiMed co-invested with Elevage in Biobeat, demonstrating direct deal overlap.
• Innovatus Capital Partners: Alternative investment firm with a dedicated healthcare/medtech strategy. Comparable as a growth-stage investor in FDA-cleared medical devices and diagnostics, with overlapping investment theses around commercialization-stage companies.
• Sofinnova Partners: European-based healthcare VC/PE firm with a dedicated medtech practice. Comparable as a sector-specialist growth-stage medtech investor targeting similar FDA-regulated device and diagnostic opportunities as Elevage.
• Perceptive Advisors: Healthcare-focused investment manager with growth and credit strategies. Comparable as a co-lead investor alongside Elevage in Imperative Care's $100M convertible, with overlapping focus on commercial-stage and growth-stage medtech.

Broad incumbents

• Deerfield Management: Large healthcare-focused investment manager across private and public markets. Comparable as a broader healthcare investment platform with growth-stage medtech exposure; larger scale but overlapping target universe of FDA-regulated device and diagnostic companies.
• Patient Square Capital: Parent sponsor and broader healthcare-focused private equity firm. Directly comparable as Elevage is a PSC-formed portfolio platform; PSC makes healthcare growth and buyout investments at a larger scale across the same medtech and healthcare services verticals.

Emerging players

• RA Capital Management: Healthcare-focused investment manager with crossover and private growth capabilities. Comparable as a healthcare specialist participating in growth-stage medtech and diagnostics financings, though with a stronger biotech tilt relative to Elevage's device focus.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments12 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Elevage Medical Technologies